A previous MR study investigated the association between ILs (IL-16, IL-18, IL-1a, IL-1ra, IL-2ra, IL-6, IL-7, IL-8, IL-12) and prostate cancer risk, and found no associations between ILs and prostate cancer risk. Here, IL16 is linked to prostate carcinoma.